LUNG TRANSPLANT; COMPLICATIONS
Clinical trials for LUNG TRANSPLANT; COMPLICATIONS explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT; COMPLICATIONS trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT; COMPLICATIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Inhaled cyclosporine aims to halt lung transplant rejection
Disease control CompletedThis Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care can improve lung function in 169 double lung transplant patients with chronic rejection. Participants inhaled the drug twice daily for 48 weeks. The main goal was to see if it slowed the de…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
Lung transplant patients test app to skip hospital trips
Disease control CompletedThis study looked at whether lung transplant patients can use an app and a home breathing test instead of going to the hospital for every check-up. 76 patients were split into two groups: one received usual care, the other used remote monitoring. The goal was to see if remote car…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: NA • Sponsor: University of Manchester • Aim: Disease control
Last updated Jun 17, 2026 12:08 UTC
-
Inhaled drug shows promise for lung transplant rejection in small trial
Disease control CompletedThis study tested an inhaled form of cyclosporine A (L-CsA) added to standard care in 62 single lung transplant patients with chronic lung rejection (bronchiolitis obliterans). The goal was to see if the combination could slow the decline in lung function over 48 weeks compared t…
Matched conditions: LUNG TRANSPLANT; COMPLICATIONS
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 17, 2026 12:05 UTC